Ibopamine challenge testing becomes negative following successful trabeculectomy surgery

Area of Science:

• Ophthalmology
• Glaucoma research
• Diagnostic test evaluation

Background:

• The ibopamine challenge test is a diagnostic tool that correlates with peak diurnal intraocular pressure (IOP).
• Its utility in assessing the effectiveness of glaucoma treatments, specifically trabeculectomy, requires further investigation.

Purpose of the Study:

• To evaluate the effect of a functioning trabeculectomy on the ibopamine challenge test's results.
• To determine if trabeculectomy alters the diagnostic outcome of the ibopamine challenge test in glaucoma patients.

Main Methods:

• A non-randomized prospective clinical trial was conducted with 13 glaucoma patients.
• Patients underwent ibopamine challenge tests (IOP measurement before and after 2% ibopamine instillation) at baseline and 12 months post-treatment.
• Treatment groups included medical management and surgical management with trabeculectomy.

Main Results:

• Initially, both medically and surgically managed groups showed a positive ibopamine challenge test (IOP increase >3 mmHg).
• After 12 months, medically managed patients remained 100% positive, while surgically managed patients showed a 0% positive response (P<0.0001).
• The change in IOP following the ibopamine challenge was significantly reduced in the surgically treated group post-trabeculectomy.

Conclusions:

• A functioning trabeculectomy renders the ibopamine challenge test negative in glaucoma patients.
• The ibopamine challenge test may serve as an indicator of successful glaucoma surgery outcomes.